Efficacy and safety of once-daily LCP-Tacrolimus versus twice-daily immediate-release tacrolimus in adult Hispanic stable kidney transplant recipients: Sub-group analysis from a phase 3 trial

Arman Faravardeh, Sanjeev Akkina, Rafael Villicana, Giselle Guerra, Misbah A. Moten, Ulf Meier-Kriesche, Daniel R. Stevens, Samir J. Patel, Suphamai Bunnapradist

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article numbere929535
JournalAnnals of Transplantation
Volume26
DOIs
StatePublished - Apr 16 2021

ASJC Scopus Subject Areas

  • Transplantation

Keywords

  • Glomerular Filtration Rate
  • Graft Rejection
  • Kidney Transplantation
  • Safety
  • Tacrolimus
  • Graft Rejection/prevention & control
  • Drug Administration Schedule
  • Humans
  • Middle Aged
  • Immunosuppressive Agents/administration & dosage
  • Male
  • Transplant Recipients
  • Hispanic or Latino
  • Adult
  • Female
  • Tacrolimus/administration & dosage

Cite this